GlassScriptPhysician profile
Keaton Nasser
NPI 1720433683
$41,355.60
in general payments reported to CMS, 2019-2025
21 companies · $2,373 in 2025
The $2,373 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $598 · 2021: $1,369 · 2022: $2,248 · 2023: $27K · 2024: $6,821 · 2025: $2,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $8,337 · Travel and Lodging: $8,071 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $8,337.08 |
| Travel and Lodging | $8,071.35 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,151.85 | 2022-2025 | Watchman Access System, Watchman Flx, Versacross Access Solution |
| Edwards Lifesciences Corporation | $10,198.91 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,044.97 | 2019-2025 | Mitraclip, Cardiomems, Amplatzer Amulet |
| Medtronic, INC. | $2,277.04 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $945.04 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $904.69 | 2019-2022 | |
| Shockwave Medical, INC | $242.55 | 2022-2025 | |
| Cvrx, INC. | $231.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $206.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $182.28 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $166.02 | 2023-2024 | Assure Wcd |
| Esperion Therapeutics, INC. | $164.90 | 2021 | |
| Cardiovascular Systems INC. | $161.39 | 2022 | |
| Medtronic Vascular, INC. | $109.01 | 2019 | |
| Chiesi USA, INC. | $93.58 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $72.59 | 2021 | |
| Cardiva Medical, INC. | $68.49 | 2023 | Cardiva Vascade 5f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Cathworks, INC. | $44.96 | 2022 | |
| Lantheus Medical Imaging, INC. | $35.22 | 2020-2021 | |
| Philips North America LLC | $29.51 | 2025 | Igt Devices Undivided |
| E.R. Squibb & Sons, L.L.C. | $23.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keaton Nasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.